vs
AbCellera Biologics Inc.（ABCL）与合众银行（FSBC）财务数据对比。点击上方公司名可切换其他公司
合众银行的季度营收约是AbCellera Biologics Inc.的1.0倍（$45.1M vs $44.9M），合众银行净利率更高（41.3% vs -19.9%，领先61.2%），过去两年AbCellera Biologics Inc.的营收复合增速更高（112.3% vs 21.3%）
AbCellera Biologics是一家总部位于不列颠哥伦比亚省温哥华的生物科技企业，核心业务是探索与开发抗体治疗药物。该公司凭借 proprietary 技术平台可在60天内开发出医疗应对方案，其单细胞筛选技术平台最早诞生于不列颠哥伦比亚大学，还曾作为核心力量参与美国国防高级研究计划局的大流行预防平台项目。
合众银行是总部设在美国明尼阿波利斯、在特拉华州注册的美国跨国银行机构，截至2025年为美国第五大银行，也是美国中西部规模最大的银行，被金融稳定委员会认定为具有系统重要性的银行。它旗下核心运营实体为美国银行全国协会，以US Bank品牌开展业务，提供银行、投资、抵押等金融服务。
ABCL vs FSBC — 直观对比
营收规模更大
FSBC
是对方的1.0倍
$44.9M
净利率更高
FSBC
高出61.2%
-19.9%
两年增速更快
ABCL
近两年复合增速
21.3%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $44.9M | $45.1M |
| 净利润 | $-8.9M | $18.6M |
| 毛利率 | — | — |
| 营业利润率 | -63.7% | — |
| 净利率 | -19.9% | 41.3% |
| 营收同比 | 788.4% | — |
| 净利润同比 | 73.9% | 42.0% |
| 每股收益（稀释后） | $-0.03 | $0.87 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABCLFSBC
| Q1 26 | — | $45.1M | ||
| Q4 25 | $44.9M | $43.5M | ||
| Q3 25 | $9.0M | $41.3M | ||
| Q2 25 | $17.1M | $38.3M | ||
| Q1 25 | $4.2M | $35.3M | ||
| Q4 24 | $5.0M | $35.2M | ||
| Q3 24 | $6.5M | $31.8M | ||
| Q2 24 | $7.3M | $30.7M |
净利润ABCLFSBC
| Q1 26 | — | $18.6M | ||
| Q4 25 | $-8.9M | $17.6M | ||
| Q3 25 | $-57.1M | $16.3M | ||
| Q2 25 | $-34.7M | $14.5M | ||
| Q1 25 | $-45.6M | $13.1M | ||
| Q4 24 | — | $13.3M | ||
| Q3 24 | $-51.1M | $10.9M | ||
| Q2 24 | $-36.9M | $10.8M |
营业利润率ABCLFSBC
| Q1 26 | — | — | ||
| Q4 25 | -63.7% | 52.9% | ||
| Q3 25 | -851.8% | 53.8% | ||
| Q2 25 | -290.2% | 52.4% | ||
| Q1 25 | -1479.6% | 52.0% | ||
| Q4 24 | — | 55.1% | ||
| Q3 24 | -1439.4% | 48.0% | ||
| Q2 24 | -1276.2% | 49.4% |
净利率ABCLFSBC
| Q1 26 | — | 41.3% | ||
| Q4 25 | -19.9% | 40.6% | ||
| Q3 25 | -637.8% | 39.6% | ||
| Q2 25 | -203.3% | 37.9% | ||
| Q1 25 | -1077.2% | 37.1% | ||
| Q4 24 | — | 37.9% | ||
| Q3 24 | -785.4% | 34.4% | ||
| Q2 24 | -504.3% | 35.2% |
每股收益（稀释后）ABCLFSBC
| Q1 26 | — | $0.87 | ||
| Q4 25 | $-0.03 | $0.83 | ||
| Q3 25 | $-0.19 | $0.77 | ||
| Q2 25 | $-0.12 | $0.68 | ||
| Q1 25 | $-0.15 | $0.62 | ||
| Q4 24 | — | $0.61 | ||
| Q3 24 | $-0.17 | $0.52 | ||
| Q2 24 | $-0.13 | $0.51 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $128.5M | $644.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $966.9M | $458.5M |
| 总资产 | $1.4B | $5.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ABCLFSBC
| Q1 26 | — | $644.4M | ||
| Q4 25 | $128.5M | — | ||
| Q3 25 | $83.2M | — | ||
| Q2 25 | $92.4M | — | ||
| Q1 25 | $159.3M | — | ||
| Q4 24 | $156.3M | — | ||
| Q3 24 | $126.6M | — | ||
| Q2 24 | $148.3M | — |
股东权益ABCLFSBC
| Q1 26 | — | $458.5M | ||
| Q4 25 | $966.9M | $445.8M | ||
| Q3 25 | $964.0M | $431.3M | ||
| Q2 25 | $1.0B | $416.7M | ||
| Q1 25 | $1.0B | $406.5M | ||
| Q4 24 | $1.1B | $396.6M | ||
| Q3 24 | $1.1B | $389.9M | ||
| Q2 24 | $1.1B | $380.5M |
总资产ABCLFSBC
| Q1 26 | — | $5.0B | ||
| Q4 25 | $1.4B | $4.8B | ||
| Q3 25 | $1.4B | $4.6B | ||
| Q2 25 | $1.4B | $4.4B | ||
| Q1 25 | $1.3B | $4.2B | ||
| Q4 24 | $1.4B | $4.1B | ||
| Q3 24 | $1.4B | $3.9B | ||
| Q2 24 | $1.4B | $3.6B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-34.7M | — |
| 自由现金流经营现金流 - 资本支出 | $-44.6M | — |
| 自由现金流率自由现金流/营收 | -99.4% | — |
| 资本支出强度资本支出/营收 | 21.9% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-174.1M | — |
8季度趋势，按日历期对齐
经营现金流ABCLFSBC
| Q1 26 | — | — | ||
| Q4 25 | $-34.7M | $72.6M | ||
| Q3 25 | $-52.6M | $18.8M | ||
| Q2 25 | $-32.4M | $17.8M | ||
| Q1 25 | $-11.6M | $15.5M | ||
| Q4 24 | $-108.6M | $51.8M | ||
| Q3 24 | $-28.9M | $17.5M | ||
| Q2 24 | $-30.0M | $16.0M |
自由现金流ABCLFSBC
| Q1 26 | — | — | ||
| Q4 25 | $-44.6M | $71.4M | ||
| Q3 25 | $-61.5M | $18.6M | ||
| Q2 25 | $-45.8M | $17.5M | ||
| Q1 25 | $-22.2M | $15.4M | ||
| Q4 24 | $-187.0M | $51.2M | ||
| Q3 24 | $-47.4M | $17.3M | ||
| Q2 24 | $-50.1M | $15.8M |
自由现金流率ABCLFSBC
| Q1 26 | — | — | ||
| Q4 25 | -99.4% | 164.3% | ||
| Q3 25 | -687.0% | 45.0% | ||
| Q2 25 | -267.9% | 45.8% | ||
| Q1 25 | -524.0% | 43.5% | ||
| Q4 24 | -3702.8% | 145.5% | ||
| Q3 24 | -728.4% | 54.5% | ||
| Q2 24 | -683.8% | 51.6% |
资本支出强度ABCLFSBC
| Q1 26 | — | — | ||
| Q4 25 | 21.9% | 2.8% | ||
| Q3 25 | 99.7% | 0.5% | ||
| Q2 25 | 78.2% | 0.6% | ||
| Q1 25 | 251.1% | 0.3% | ||
| Q4 24 | 1552.7% | 1.8% | ||
| Q3 24 | 284.6% | 0.7% | ||
| Q2 24 | 274.6% | 0.7% |
现金转化率ABCLFSBC
| Q1 26 | — | — | ||
| Q4 25 | — | 4.12× | ||
| Q3 25 | — | 1.15× | ||
| Q2 25 | — | 1.23× | ||
| Q1 25 | — | 1.18× | ||
| Q4 24 | — | 3.89× | ||
| Q3 24 | — | 1.60× | ||
| Q2 24 | — | 1.49× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ABCL
暂无分部数据
FSBC
| Net Interest Income | $43.5M | 96% |
| Noninterest Income | $1.6M | 4% |
